During development and for maintenance of tissue homeostasis, division and differentiation of cells are regulated in an inverse and highly coordinated manner. Differentiation of cells occurs at multiple steps as a multicellular organism develops and as a simple zygote develops into a highly complex system of specialized tissues and cell types. Differentiation also occurs in adults during processes such as tissue repair after injury and normal turnover of cells. In adults, somatic stem cells divide, and fully differentiated daughter cells are produced to fill these roles.
Acetylcholine (ACh) functions as a classical neurotransmitter at synapses in the central nervous system, parasympathetic nervous system, and neuromuscular junctions. Muscarine and nicotine, which are found naturally, have been used to classify cholinergic receptors into two general categories, muscarinic and nicotinic. Muscarinic actions are generally slower than nicotinic actions. Muscarinic effects last longer and show a different anatomical location. Highly selective antagonists bind to muscarinic receptors. Five muscarinic receptor subtypes (M1-M5) have been identified using selective agonists, inverse agonists, and molecular biology techniques.
The physiological importance of muscarinic receptors
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(mAChRs) is well known in the mammalian nervous system. However, new data show that ACh is also ubiquitously found in non-neuronal tissue throughout the rest of the body. ACh is also found in prokaryotes and eukaryotes including bacteria and plants [1] [2] [3] . Thus, ACh likely plays a role in mediating and regulating various functions such as division, differentiation, and establishment of cell-cell contacts; ACh may have paracrine and autocrine functions as well [3, 4] . Thus, in addition to the classical role in the nervous system, an emerging concept is that functional ACh is synthesized by and released from non-neuronal cells [5] . mAChRs are G protein-coupled receptors. G proteins, which are composed of one α-, one β-, and one γ-subunit, are guanine nucleotide-binding proteins that regulate second messengers and ion channels [6] . G proteins are classified as Gαs, Gαi/o, Gαq, and Gα12 based on the primary sequence homology of the α-subunits [7] . Following receptor activation, the G protein dissociates into α-and β/γ-subunits, the former of which is mainly responsible for intracellular signaling. G protein subunits activate various signaling pathways, and the different mAChRs are coupled to different G proteins. The 'odd-numbered' receptors (M1, M3, and M5) are generally coupled to the Gαq family of G proteins and regulate phosphoinositide metabolism and intracellular calcium levels. M1, M3, and M5 receptors generally increase intracellular calcium by mobilizing phosphoinositides that generate inositol 1,4,5-trisphosphate and 1,2-diacylglycerol [8] . The 'even-numbered' receptors (M2, M4) are mainly coupled to the Gαi family and inhibit adenylate cyclase, thus decreasing the second messenger, cyclic adenosine monophosphate. mAChRs also modulate other signaling pathways to control inflammation, cell growth, and proliferation [8] . The various signaling mechanisms controlled by mAChRs are complex and modulate multiple functions in neurons and in non-neuronal cells.
We recently showed that ACh is synthesized in non-neuronal cells in the mouse intestinal tract [9] . Using biochemical, enzymological, and high-throughput reverse-phase nano-flow mass spectrometry techniques, we showed that ACh is synthesized and released by intestinal organoids that do not have neurons or immune cells [10] . We also used immunohistochemistry, tandem imaging mass spectrometry, and molecular biology techniques to show that the intestinal epithelium expresses ACh receptors and other components of the cholinergic system. Pharmacological studies with the cholinergic agonist carbachol demonstrated that ACh inhibits growth and differentiation in these organoids. Carbachol does not modulate expression of Lgr5, a gene that is expressed in intestinal stem cells [9] , and thus, ACh likely modulates growth of organoids via other mechanisms. ACh may contribute to maintaining Lgr5-positive stem cells in an undifferentiated state in which enterocytes, goblet cells, Paneth cells, and enteroendocrine cells, which are the cells of the intestinal epithelium, are not produced. In contrast to carbachol, the antimuscarinic agent atropine enhances the growth and differentiation of organoids. Thus, ACh inhibits growth and differentiation in organoids via activation of mAChRs.
Additional investigation showed that growth and Lgr5 transcription were increased in organoids treated with the M1, M2, and M3 antagonists pirenzepine, AF-DX-116, and 4-DAMP, respectively. In contrast, the M4 antagonist tropicamide had no effect on growth of organoids and decreased Lgr5 transcription [9] . Thus, the M1, M2, and M3 mAChR subtypes likely regulate activation of Lgr5-positive stem cells. mAChRs on epithelial and/or Lgr5-positive stem cells may indirectly regulate the rate of turnover of the intestinal epithelium.
M1-M5 are highly expressed in most cancer cells and regulate multiple functions, including proliferation in particular [11, 12] . This effect of mAChRs is at least partly mediated by the classical inositol-phospholipid signaling cascade [8] . However, transactivation between two pathways complicates the situation. In addition to inositol-phospholipid signaling, mAChRs are also coupled to the mitogen-activated protein kinase pathway, which likely occurs due to transactivation of the epidermal growth factor (EGF) receptor [11, 13, 14, 15, 16] , which is expressed on the basolateral membranes of the crypt cell epithelium [17] . Growth of isolated crypts in Matrigel in the presence of EGF produces crypt-villus organoids [10] . Murine Paneth cells express EGF, which is necessary to maintain cultured stem cells in a stemness state [18] . As mentioned above, our previous studies revealed that non-neuronal ACh plays a role in the maintenance and differentiation of Lgr5-positive stem cells [9] . We suggest that EGF produced by Paneth cells may stimulate stem cell proliferation due to transactivation of the EGF receptor via mAChRs. This effect is controlled by epithelial cells, which produce ACh to inhibit stem cell commitment to epithelial cell differentiation without transactivation of the EGF receptor. EGF and ACh may regulate the effects of the other factor, or these two factors may affect different steps in the differentiation pathway.
Our data collectively suggest that ACh produced by non-neuronal cells plays a role in the maintenance and differentiation of Lgr5-positive stem cells and thus modulates intestinal epithelial cell density and homeostasis. The presence of a non-neuronal cholinergic system supports the notion that a novel combinatorial pathway may be controlled by cholinergic and antagonistic signals such as Wnt, the latter of which induces changes in the typical shape of the crypt-villus, resulting in spherical cysts without differentiated cells [18] . Further investigation of this pathway may help elucidate the steps in development of the crypt-villus axis.
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